Likely Massive Dividend Cut Means You Should Avoid HCP And Buy These 2 High-Yielding REITs Instead

Posted On June 21, 2016 7:51 pm

HCP has one of the most impressive dividend growth records of any stock in America. BUT that track record is likely to come to an end next year. Find out why, and more importantly, which two high-yielding alternative medical REITs can do a better job of meeting your dividend growth needs.

Continue Reading Here

About author

Dividend Sensei
Dividend Sensei

I'm an Army veteran and former energy dividend writer for The Motley Fool. I'm a proud co-founder of Wide Moat Research, Dividend Kings, and the Intelligent Dividend Investor. My work can be found on Seeking Alpha, Dividend Kings, iREIT, and the Intelligent Dividend Investor. My goal is to help all people learn how to harness the awesome power of dividend growth investing to achieve their financial dreams and enrich their lives. With 24 years of investing experience, I've learned what works and more importantly, what doesn't, when it comes to building long-term wealth and income streams and achieving long-term financial goals.

Related Articles

Leave a reply

Your email address will not be published. Required fields are marked *